· Insider activity · JNJ
Johnson & Johnson (JNJ) insider filing adds an executive acquisition
The update gives investors a fresh ownership datapoint as the drugmaker is viewed through weekly market data rather than live intraday action.
Johnson & Johnson (JNJ) reported insider activity dated June 11 for Kathryn E. Wengel, EVP, Chief TO and Risk Officer. The filing listed an acquisition of 10,000 common shares at 115.67 USD per share.
The stock’s weekly setup is constructive on price but not one-way. The trend screen remains active and Relative Strength is 7.9, while Market Dynamics shows pressure at -0.79.